In addition, this study also provides clues for evaluating the efficacy of DC‐CIK cells; when DC‐CIK immunotherapy is required, whether the TNFR1 molecule is expressed on the surface of cancer cells should be assessed beforehand. The gene discussed is TNFRSF1A; the disease is cancer.